REQUEST A DEMO
Total
USD $0.00
Search more companies

Bukalo Trading Company Limited (Thailand)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Bukalo Trading Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Bukalo Trading Company Limited is a company based in Thailand, with its head office in Bangkok , Special Governed District of. It operates in the Pharmaceutical Preparation Manufacturing industry. It was incorporated on May 15, 1988. There are currently 15 (2024) people employed by Bukalo Trading Company Limited. The latest financial highlights indicate a net sales revenue increase of 14.81% in 2024. During that time, Bukalo Trading Company Limited’s total assets decreased by 4.8%. In, 2024, the company’s net profit margin decreased by 2.3%.

Headquarters
9 Chaloem Prakiat Road Soi Chaloem Prakiat R.9 Soi 30
Bangkok , Special Governed District of; Central Thailand; Postal Code: 10250

Contact Details: Purchase the Bukalo Trading Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Bukalo Trading Company Limited report to view the information.
Financial Auditors:
Purchase the Bukalo Trading Company Limited report to view the information.
Incorporation Date:
May 15, 1988
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Bukalo Trading Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
14.81%
Total Operating Revenue
13.88%
Operating Profit
-16.11%
EBITDA
-16.11%
Net Profit/Loss for the Period
-25.64%
Total Assets
-4.8%
Total Equity
9.45%
Operating Profit Margin
-3.46%
Net Profit Margin
-2.3%
Return on Equity (ROE)
-4.08%
Debt / Equity
-72.52%
Quick Ratio
0.07%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?